Uncoordinated regulation of mRNA expression of the three isoforms of transforming growth factor-β in the mouse skin carcinogenesis model

Molecular Carcinogenesis

Volumn 18, Issue 2, 1997, Pages 115-126

  Rundhaug, Joyce E ^a   Park, Jeanie ^a   Fischer, Susan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

CH72 cells; Mouse skin keratinocytes; Squamous cell carcinoma; Transforming growth factor

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TUMOR CELL LINE;

ANIMALS; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; PAPILLOMA; RNA, MESSENGER; SKIN NEOPLASMS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030893176     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199702)18:2<115::AID-MC7>3.0.CO;2-F     Document Type: Article

References (66)

1. Sollberg S, Ryynänen J, Olsen DR, Uitto J. Transforming growth factor-β up-regulates the expression of the genes for β4 integrin and bullous pemphigoid antigens (BPAG1 and BPAG2) in normal and transformed human keratinocytes. J Invest Dermatol 99:409-414, 1992.
2. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, Derynck R. Human transforming growth factor-β3: Recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2. Mol Endocrinol 3:1977-1986, 1989.
3. Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massaqué J. Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 265:20533-20538, 1990.
4. Bassing CH, Howe DJ, Segarini PR, Donahoe PK, Wang X-F. A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-β ligands. J Biol Chem 269:14861-14864, 1994.
5. Segarini PR. TGF-β receptors: A complicated system of multiple binding proteins. Biochim Biophys Acta 1155:269-275, 1993.
6. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105, 1991.
7. Miller DA, Lee A, Pelton RW, Chen EY, Moses HL, Derynck R. Murine transforming growth factor-β2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol 3:1108-1114, 1989.
8. Miller DA, Lee A, Matsui Y, Chen EY, Moses HL, Derynck R. Complementary DNA cloning of the murine transforming growth factor-β3 (TGFβ3) precursor and the comparative expression of TGFβ3 and TGFβ1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol 3:1926-1934, 1989.
9. Denhez F, Lafyatis R, Kondaiah P, Roberts AB, Sporn MB. Cloning by polymerase chain reaction of a new mouse TGF-β, mTGF-β3. Growth Factors 3:139-146, 1990.
10. Schmid P, Cox D, van der Putten H, McMaster GK, Bilbe G. Expression of TGF-βs and TGF-β type II receptor mRNAs in mouse folliculogenesis: Stored maternal TGF-β2 message in oocytes. Biochem Biophys Res Commun 201:649-656, 1994.
11. Derynck R, Lindquist PB, Lee A, et al. A new type of transforming growth factor-β, TGF-β3. EMBO J 7:3737-3743, 1988.
12. Jakowlew SB, Mead JE, Danielpour D, Wu J, Roberts AB, Fausto N. Transforming growth factor-β (TGF-β) isoforms in rat liver regeneration: Messenger RNA expression and activation of latent TGF-β. Cell Regulation 2:535-548, 1991.
13. Takahashi T, Eitzman B, Bossert NL, et al. Transforming growth factors β1 β2 and β3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: A comparison to other estrogen-regulated genes. Cell Growth Differ 5:919-935, 1994.
14. Hubbs AF, Hahn FF, Thomassen DG. Increased resistance to transforming growth factor beta accompanies neoplastic progression of rat tracheal epithelial cells. Carcinogenesis 10:1599-1605, 1989.
15. Valverius EM, Walker-Jones D, Bates SE, et al. Production of and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells. Cancer Res 49:6269-6274, 1989.
16. 1 during the spontaneous transformation of rat liver epithelial cells. Cancer Res 51:5929-5936, 1991.
17. Game SM, Huelsen A, Patel V, et al. Progressive abrogation of TGF-β1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Int J Cancer 52:461-470, 1992.
18. Blaydes JP, Wynford-Thomas D. Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumour progression. Int J Cancer 65:525-530, 1996.
19. Kadin ME, Cavaille-Coll MW, Gertz R, Massagué J, Cheitetz S, George D. Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc Natl Acad Sci USA 91:6002-6006, 1994.
20. Kalkhoven E, Roelen BAJ, de Winter JP, et al. Resistance to transforming growth factor-β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 6:1151-1161, 1995.
21. Park K, Kim S-J, Bang Y-J, et al. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 91:8772-8776, 1994.
22. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995.
23. Kim IY, Ahn H-J, Zelner DJ, et al. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 56:44-48, 1996.
24. Schwarz LC, Wright JA, Gingras M-C, et al. Aberrant TGF-β production and regulation in metastatic malignancy. Growth Factors 3:115-127, 1990.
25. Krieg P, Schnapke R, Fürstenberger G, Vogt I, Marks F. TGF-β1 and skin carcinogenesis: Antiproliferative effect in vitro and TGF-β1 mRNA expression during epidermal hyperproliteration and multistage tumongenesis. Mol Carcinog 4:129-137, 1991.
26. 1 associates with disease progression in human breast cancer. Cancer Res 52:6949-6952, 1992.
27. Thompson TC, Truong LD, Timme TL, et al. Transgenic models for the study of prostate cancer. Cancer 71:1165-1171, 1993.
28. Patamalai B, Burow DL, Gimenez-Conti I, et al. Altered expression of transforming growth factor-β1 mRNA and protein in mouse skin carcinogenesis. Mol Carcinog 9:220-229, 1994.
29. Cui W, Fowlis DJ, Bryson S, et al. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542, 1996.
30. Glick AB, Kulkarni AB, Tennenbaum T, et al. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 90:6076-6080, 1993.
31. Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S, Yuspa SH. Targeted deletion of the TGF-β1 gene causes rapid progression to sguamous cell carcinoma. Genes Dev 8:2429-2440, 1994.
32. null mice is prognostic for a high risk of malignant conversion. Cancer Res 54:5831-5836, 1994.
33. Comerci JT Jr, Runowicz CD, Flanders KC, et al. Altered expression of transforming growth factor-β1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer 77:1107-1114, 1996.
34. Schmid P, Itin P, Rufli T. In situ analysis of transforming growth factor-βs (TGF-β1, TGF-β2, TGF-β3), and TGF-β type II receptor expression in malignant melanoma. Carcinogenesis 16:1499-1503, 1995.
35. Gold LI, Saxena B, Mittal KR, et al. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: Evidence for paracrine and autocrine action. Cancer Res 54:2347-2358, 1994.
36. McCune BK, Patterson K, Chandra RS, Kapur S, Sporn MB, Tsokos M. Expression of transforming growth factor-β isoforms in small round cell tumors of childhood. An immunohistochemical study. Am J Pathol 142:49-58, 1993.
37. DiGiovanni J. Multistage skin carcinogenesis in mice. In: Waalkes MP, Ward JM (eds), Carcinogenesis. Raven Press, New York, 1994, pp.265-299.
38. Yuspa SH. The pathogenesis of sguamous cell cancer: Lessons learned from studies of skin carcinogenesis - Thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 54:1178-1189, 1994.
39. 1 RNA and protein localization during chemical carcinogenesis of the skin. Cell Growth Differ 3:81-91, 1992.
40. 3 down-modulation in 12-O-tetradecanoylphorbol-13-acetate-induced skin hyperplasia. Cancer Res 53:5517-5522, 1993.
41. Glick AB, Danielpour D, Morgan D, Sporn MB, Yuspa SH. Induction and autocrine receptor binding of transforming growth factor-β2 during terminal differentiation of primary mouse keratinocytes. Mol Endocrinol 4:45-52, 1990.
42. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J Biol Chem 263:7741-7746, 1988.
43. Bascom CC, Wolfshohl JR, Coffey RJ Jr, et al. Complex regulation of transforming growth factor β1, β2, and β3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors β1 and β2. Mol Cell Biol 9:5508-5515, 1989.
44. Kim S-J, Jeang K-T, Glick AB, Sporn MB, Roberts AB. Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction. J Biol Chem 264:7041-7045, 1989.
45. Conti CJ, Fries JW, Viaje A, Miller DR, Morris R, Slaga TJ. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Res 48:435-439, 1988.
46. Brunner AM, Marquardt H, Malacko AR, Lioubin MN, Purchio AF. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264:13660-13664, 1989.
47. Lopez AR, Cook J, Deininger PL, Derynck R. Dominant negative mutants of transforming growth factor-β1 inhibit the secretion of different transforming growth factor-β isoforms. Mol Cell Biol 12:1674-1679, 1992.
48. Yuspa SH, Harris CC. Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp Cell Res 86:95-105, 1974.
49. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
50. Derynck R, Jarrett JA, Chen EY, Goeddel DV. The murine transforming growth factor-β precursor. J Biol Chem 261:4377-4379, 1986.
51. Roop DR, Hawley-Nelson P, Cheng CK, Yuspa SH. Keratin gene expression in mouse epidermis and cultured epidermal cells. Proc Natl Acad Sci USA 80:716-720, 1983.
52. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 109:1207-1217, 1989.
53. Balmain A, Krumlauf R, Vass JK, Birnie GD. Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res 10:4259-4277, 1982.
54. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell 19:245-254, 1980.
55. Roberts AB, Sporn MB. The transforming growth factor-betas. In: Sporn MB, Roberts AB (eds), Peptide Growth Factors and Their Receptors. Springer-Verlag, Heidelberg, 1990, pp 419-472.
56. Missero C, Ramon y Cajal S, Dotto GP. Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc Natl Acad Sci USA 88:9613-9617, 1991.
57. Millan FA, Denhez F, Kondaiah P, Akhurst RJ. Embryonic expression patterns of TGFβ1, β2 and β3 suggest different functions in vivo. Development 111:131-144, 1991.
58. 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ 4:115-123, 1993.
59. + T cell function. Jpn J Cancer Res 84:315-325, 1993.
60. Ueki N, Nakazato M, Ohkawa T, et al. Excessive production of transforming growth factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: Validity of neutralizing antibodies to block tumor growth. Biochim Biophys Acta 1137:189-196, 1992.
61. Welch DR, Fabra A, Nakajima M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87:7678-7682, 1990.
62. 1 (Ser223, 225). EMBO J 11:1599-1605, 1992.
63. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-β receptor. Nature 370:341-347, 1994.
64. Koli K, Arteaga CL. Predominant cytosolic localization of TGFβ-type II receptors (IIR) in human breast carcinoma cells. Abstract. Proceedings of the American Association for Cancer Research 37:37, 1996.
65. Glick AB, Sporn MB, Yuspa SH. Altered regulation of TGF-β1 and TGF-α in primary keratinocytes and papillomas expressing v-Ha-ras. Mol Carcinog 4:210-219, 1991.
66. 1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90:5237-5241, 1993.